This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Study Confirms REGRANEX® Is Effective Treatment Of Foot Ulcers

Posted: Thursday, February 16, 2006

The retrospective patient cohort study utilized a claims database to evaluate more than 24,000 patients with neuropathic diabetic foot ulcers who were treated at specialty wound clinics between 1998 and 2004. Patients who had received REGRANEX® were more likely to have healed at 20 weeks versus those treated with other methods of ulcer care. These results were similar to the results of previous randomized controlled trials of REGRANEX® Gel.

"Clinical studies show how something works in an ideal setting," stated David J. Margolis, M.D., Ph.D., Departments of Dermatology and Biostatistics and Epidemiology, University of Pennsylvania School of Medicine and lead researcher. "Our study looked at how REGRANEX® performs in clinical practice and demonstrated that it achieves similar results in the real world as in the ideal setting."

REGRANEX® Gel is indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and have an adequate blood supply. When used as an adjunct to, and not a substitute for, good ulcer care practices including initial sharp debridement, pressure relief and infection control, REGRANEX® Gel increases the incidence of complete healing of diabetic ulcers.

The efficacy of REGRANEX® Gel has not been established for treatment of pressure ulcers and venous stasis ulcers (see Clinical Studies), and has not been evaluated for the treatment of diabetic neuropathic ulcers that do not extend through the dermis into subcutaneous tissue (Stage I or II, IAET staging classification) or ischemic diabetic ulcers.

Source: diabetes In Control: